Viewing data from:

DESOXIMETASONE

ANDA

DESOXIMETASONE | A205082 | ACTAVIS MID ATLANTIC LLC

1 strength0 unique patents0 unique exclusivities

API Supply Chain5 active DMFs2 inactive

4 active API suppliers hold Drug Master Files for this ingredient.

TARO PHARMACEUTICAL INDUSTRIES LTDDESOXIMETASONE USP

DMF 138611998

EUROAPI FRANCEDESOXIMETASONE USP, MICRONIZED

DMF 148522000

FARMABIOS SPADESOXIMETASONE

DMF 177592004

SYMBIOTEC PHARMALAB PRIVATE LTDDESOXIMETASONE USP (MICRONIZED)

DMF 224002009

TARO PHARMACEUTICAL INDUSTRIES LTDDESOXIMETASONE USP, MICRONIZED

DMF 268412013

SOCIETA ITALIANA CORTICOSTEROIDI SPAInactiveDESOXIMETASONE

DMF 74241988

TARO PHARMACEUTICAL INDUSTRIES LTDInactiveDESOXIMETASONE

DMF 110181994

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Sep 9, 2015	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — 0.25%

0 patents0 exclusivities▴

CREAM;TOPICAL | Approved: Sep 4, 2015

No patent or exclusivity listings for this strength.